FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion...

Diageo Plc FY25 profit down 28%, free cash flow rises to $2.7bn

Diageo reported FY25 operating profit of $4.3bn, down 27.8%, impacted by exceptional costs and currency headwinds. Organic net sales rose 1.7%, while free cash flow increased to $2.7bn. The group raised its cost savings target to $625m and reaffirmed its outlook for mid-single-digit profit growth in FY26...

BP Plc reports $2.4bn Q2 underlying profit, launches $750m buyback

BP delivered a $2.4bn underlying replacement cost profit in Q2 2025, supported by strong trading and refining margins. Operating cash flow reached $6.3bn, and net debt fell to $26.0bn. The company declared a dividend of 8.32 cents per share and announced a $750m share buyback...

Fresnillo H1 profit up 297% with $1bn free cash flow and higher dividend

Fresnillo plc reported a 297% rise in H1 2025 profit to $467.6m, driven by stronger metals prices, disciplined cost control, and a 16% increase in gold output. Free cash flow rose to $1.03bn, supporting a 20.8 cent interim dividend...

Pearson Plc on track to deliver 2025 guidance

Pearson plc reported H1 2025 sales of £1.72 billion, up 2% on an underlying basis, with adjusted operating profit also rising 2% to £242 million. Free cash flow jumped £129 million to £156 million, boosted by a £114 million State Aid tax recovery...

Intertek Group delivers strong H1 2025 with double-digit EPS growth

Intertek Group plc reported H1 2025 revenue of £1.67 billion, up 4.5% at constant currency, with adjusted EPS rising 12.6%. Operating profit increased 9.7% to £276.3 million and margin improved by 80bps...

IAG reports €1.88bn H1 profit on strong travel demand

International Consolidated Airlines Group posted a 43.5% rise in H1 2025 operating profit to €1.88 billion, driven by resilient passenger demand, lower fuel costs and strong performance across its brands...

BAE Systems upgrades 2025 outlook after strong H1 performance

BAE Systems reported an 11% rise in H1 sales to £14.6bn and a 13% increase in underlying EBIT to £1.55bn, prompting an upgrade to full-year sales and profit guidance...

Sage Group Plc reports 9% revenue growth, reaffirms FY25 outlook

Sage Group (LON:SGE) reported a 9% year-on-year rise in total revenue to £1.86bn for the nine months to 30 June 2025. Strong growth was driven by Sage Business Cloud (+13%) and recurring revenue (+10%)...

GSK raises 2025 guidance after strong Q2 performance

GSK reported Q2 2025 turnover of £8.0bn, up 6% CER, with strong growth in Specialty Medicines (+15%) and Vaccines (+9%). Core EPS rose 15% to 46.5p...

Glencore delivers 5% H1 CuEq growth and $1bn cost savings plan

Glencore has reported a 5% year-on-year increase in copper equivalent production for H1 2025, driven by the integration of EVR’s steelmaking coal volumes. Copper output declined due to planned sequencing, cobalt and zinc production rose...

Croda H1 2025 sales Up 7% with adjusted profit before tax up 8%

Croda International delivered group sales of £855.8 m in the half year to 30 June 2025, up 7% at constant currency, with adjusted EBITDA rising 11% to £198.5 m and adjusted operating profit up 12% to £146.9 m...

Entain’s BetMGM delivers 36% revenue growth and raises FY25 guidance

BetMGM LLC reported 2Q 2025 net revenue of $692 million, up 36% year‑on‑year, with EBITDA of $86 million (up $78 million) and 1H net revenue of $1.35 billion (up 35%) with EBITDA of $109 million (up $232 million)...

Barclays Plc H125 Interim Results: RoTE 13.2% and £1.4 bn capital distributions

Barclays delivered a profit before tax of £5.2 bn and a return on tangible equity of 13.2 per cent in the first half of 2025, with income up 12 per cent to £14.9 bn and EPS rising to 24.7 p...

GSK and Hengrui Pharma to develop up to 12 new medicine programmes

GSK plc has entered agreements with Hengrui Pharma to develop up to 12 innovative medicines, including an exclusive worldwide licence (ex‑China) for HRS‑9821, a potential best‑in‑class PDE3/4 inhibitor for COPD, for $500 million in upfront fees and up to $12 billion in milestone payments...

NatWest Group Plc reports H1 2025 profit rise of 28%, dividend up 58%

NatWest Group delivered an attributable profit of £2.5 billion in H1 2025, with earnings per share up 28% to 30.9 pence, Return on Tangible Equity of 18.1% and a cost:income ratio improved to 48.8%...

Rightmove reports strong H1 2025; 10% revenue rise and strategic growth

Rightmove plc today announces unaudited results for the six months to 30 June 2025, with revenue up 10% to £211.7 million, operating profit up 10% to £145.4 million and strategic growth area delivering a combined 37% year-on-year increase as partner retention hits a decade high and AI-driven innovation accelerates...

Centrica H1 2025 interim results: EBITDA £900 m, dividend +22%

Centrica delivered resilient H1 2025 performance with adjusted EBITDA of £900 m and free cash flow of £244 m, while net cash stood at £2.5 bn..

Anglo American reports iron ore and manganese surge in Q2

In Q2 2025, copper production reached 173 kt, down 11% year‑on‑year but up 3% quarter‑on‑quarter, iron ore output rose 2% to 15.9 Mt and manganese surged 109% after operations resumed...
Search

Funds

FTSE 100

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion...

Diageo Plc FY25 profit down 28%, free cash flow rises to $2.7bn

Diageo reported FY25 operating profit of $4.3bn, down 27.8%, impacted by exceptional costs and currency headwinds. Organic net sales rose 1.7%, while free cash flow increased to $2.7bn. The group raised its cost savings target to $625m and reaffirmed its outlook for mid-single-digit profit growth in FY26...

BP Plc reports $2.4bn Q2 underlying profit, launches $750m buyback

BP delivered a $2.4bn underlying replacement cost profit in Q2 2025, supported by strong trading and refining margins. Operating cash flow reached $6.3bn, and net debt fell to $26.0bn. The company declared a dividend of 8.32 cents per share and announced a $750m share buyback...

Fresnillo H1 profit up 297% with $1bn free cash flow and higher dividend

Fresnillo plc reported a 297% rise in H1 2025 profit to $467.6m, driven by stronger metals prices, disciplined cost control, and a 16% increase in gold output. Free cash flow rose to $1.03bn, supporting a 20.8 cent interim dividend...

Pearson Plc on track to deliver 2025 guidance

Pearson plc reported H1 2025 sales of £1.72 billion, up 2% on an underlying basis, with adjusted operating profit also rising 2% to £242 million. Free cash flow jumped £129 million to £156 million, boosted by a £114 million State Aid tax recovery...

Intertek Group delivers strong H1 2025 with double-digit EPS growth

Intertek Group plc reported H1 2025 revenue of £1.67 billion, up 4.5% at constant currency, with adjusted EPS rising 12.6%. Operating profit increased 9.7% to £276.3 million and margin improved by 80bps...

IAG reports €1.88bn H1 profit on strong travel demand

International Consolidated Airlines Group posted a 43.5% rise in H1 2025 operating profit to €1.88 billion, driven by resilient passenger demand, lower fuel costs and strong performance across its brands...

BAE Systems upgrades 2025 outlook after strong H1 performance

BAE Systems reported an 11% rise in H1 sales to £14.6bn and a 13% increase in underlying EBIT to £1.55bn, prompting an upgrade to full-year sales and profit guidance...

Sage Group Plc reports 9% revenue growth, reaffirms FY25 outlook

Sage Group (LON:SGE) reported a 9% year-on-year rise in total revenue to £1.86bn for the nine months to 30 June 2025. Strong growth was driven by Sage Business Cloud (+13%) and recurring revenue (+10%)...

GSK raises 2025 guidance after strong Q2 performance

GSK reported Q2 2025 turnover of £8.0bn, up 6% CER, with strong growth in Specialty Medicines (+15%) and Vaccines (+9%). Core EPS rose 15% to 46.5p...

Glencore delivers 5% H1 CuEq growth and $1bn cost savings plan

Glencore has reported a 5% year-on-year increase in copper equivalent production for H1 2025, driven by the integration of EVR’s steelmaking coal volumes. Copper output declined due to planned sequencing, cobalt and zinc production rose...

Croda H1 2025 sales Up 7% with adjusted profit before tax up 8%

Croda International delivered group sales of £855.8 m in the half year to 30 June 2025, up 7% at constant currency, with adjusted EBITDA rising 11% to £198.5 m and adjusted operating profit up 12% to £146.9 m...

Entain’s BetMGM delivers 36% revenue growth and raises FY25 guidance

BetMGM LLC reported 2Q 2025 net revenue of $692 million, up 36% year‑on‑year, with EBITDA of $86 million (up $78 million) and 1H net revenue of $1.35 billion (up 35%) with EBITDA of $109 million (up $232 million)...

Barclays Plc H125 Interim Results: RoTE 13.2% and £1.4 bn capital distributions

Barclays delivered a profit before tax of £5.2 bn and a return on tangible equity of 13.2 per cent in the first half of 2025, with income up 12 per cent to £14.9 bn and EPS rising to 24.7 p...

GSK and Hengrui Pharma to develop up to 12 new medicine programmes

GSK plc has entered agreements with Hengrui Pharma to develop up to 12 innovative medicines, including an exclusive worldwide licence (ex‑China) for HRS‑9821, a potential best‑in‑class PDE3/4 inhibitor for COPD, for $500 million in upfront fees and up to $12 billion in milestone payments...

NatWest Group Plc reports H1 2025 profit rise of 28%, dividend up 58%

NatWest Group delivered an attributable profit of £2.5 billion in H1 2025, with earnings per share up 28% to 30.9 pence, Return on Tangible Equity of 18.1% and a cost:income ratio improved to 48.8%...

Rightmove reports strong H1 2025; 10% revenue rise and strategic growth

Rightmove plc today announces unaudited results for the six months to 30 June 2025, with revenue up 10% to £211.7 million, operating profit up 10% to £145.4 million and strategic growth area delivering a combined 37% year-on-year increase as partner retention hits a decade high and AI-driven innovation accelerates...

Centrica H1 2025 interim results: EBITDA £900 m, dividend +22%

Centrica delivered resilient H1 2025 performance with adjusted EBITDA of £900 m and free cash flow of £244 m, while net cash stood at £2.5 bn..

Anglo American reports iron ore and manganese surge in Q2

In Q2 2025, copper production reached 173 kt, down 11% year‑on‑year but up 3% quarter‑on‑quarter, iron ore output rose 2% to 15.9 Mt and manganese surged 109% after operations resumed...
Search

Funds

FTSE 100

FTSE 100

Funds